iShares Biotechnology ETF $IBB Shares Purchased by Lighthouse Financial LLC

Lighthouse Financial LLC boosted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 89.7% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 17,966 shares of the financial services provider’s stock after acquiring an additional 8,496 shares during the quarter. iShares Biotechnology ETF comprises about 1.7% of Lighthouse Financial LLC’s portfolio, making the stock its 20th largest position. Lighthouse Financial LLC’s holdings in iShares Biotechnology ETF were worth $3,782,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. IFP Advisors Inc lifted its holdings in shares of iShares Biotechnology ETF by 39.3% during the second quarter. IFP Advisors Inc now owns 49,988 shares of the financial services provider’s stock worth $9,507,000 after purchasing an additional 14,115 shares during the period. Security National Bank of Sioux City Iowa IA increased its holdings in iShares Biotechnology ETF by 31.8% in the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 12,187 shares of the financial services provider’s stock worth $2,318,000 after buying an additional 2,939 shares during the period. Kestra Advisory Services LLC increased its holdings in iShares Biotechnology ETF by 12.2% in the 1st quarter. Kestra Advisory Services LLC now owns 47,461 shares of the financial services provider’s stock worth $8,014,000 after buying an additional 5,155 shares during the period. The Manufacturers Life Insurance Company raised its position in iShares Biotechnology ETF by 64.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock worth $19,369,000 after buying an additional 39,760 shares during the last quarter. Finally, Navellier & Associates Inc. purchased a new position in iShares Biotechnology ETF during the 2nd quarter worth approximately $531,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $207.74 on Friday. iShares Biotechnology ETF has a 12 month low of $154.62 and a 12 month high of $217.12. The company has a 50 day simple moving average of $207.88 and a two-hundred day simple moving average of $189.30.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Tuesday, September 15th were issued a dividend of $0.0112 per share. This represents a $0.04 annualized dividend and a yield of 0.0%. This is a negative change from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. The ex-dividend date of this dividend was Tuesday, September 15th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.